Investigating the effect of attentalin in children with attention deficit hyperactivity disorder

Investigation the effect of Attentalin on the severity of symptom of sustained attention and selective attention in children with attention deficit hyperactivity disorder

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241019063419N1

Enrollment

118

Registered

2024-10-23

Start date

2024-11-05

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit hyperactivity disorder. Attention-deficit hyperactivity disorder, predominantly inattentive type

Interventions

Intervention 1: Intervention group: quick-release methylphenidate (Porsina company product) 5 mg once or twice a day + attantalin syrup (product of Simorgh Daru Atar company) 10 cc twice a day. In thi

Eligibility

Sex/Gender

All

Age

8 Years to 14 Years

Inclusion criteria

Inclusion criteria: Patients with attention deficit hyperactivity disorder Informed consent of the patient's parents or legal guardian to participate in the study Children 8 to 14 years old

Exclusion criteria

Exclusion criteria: History of drug side effects after taking attentalin

Design outcomes

Primary

Measure	Time frame
The score of symptoms of selective attention deficit in the computerized Stroop test. Timepoint: Measuring the severity of symptoms of selective attention deficit at the beginning of the study (before the start of the intervention) and 8 weeks after taking attentalin. Method of measurement: Computerized Stroop test.;Continuous attention deficit symptom score in CPT computerized test. Timepoint: Measuring the severity of persistent attention deficit symptoms at the beginning of the study (before the start of the intervention) and 8 weeks after taking attentalin. Method of measurement: Computerized CPT test.	—

Measure

Time frame

The score of symptoms of selective attention deficit in the computerized Stroop test. Timepoint: Measuring the severity of symptoms of selective attention deficit at the beginning of the study (before the start of the intervention) and 8 weeks after taking attentalin. Method of measurement: Computerized Stroop test.;Continuous attention deficit symptom score in CPT computerized test. Timepoint: Measuring the severity of persistent attention deficit symptoms at the beginning of the study (before the start of the intervention) and 8 weeks after taking attentalin. Method of measurement: Computerized CPT test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoraya Yadegari

Arak University of Medical Sciences

yadegarisoraya@gmail.com+98 86 3313 4717

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026